LLYON
li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Name LLYON
Rank No.1231
Market Cap $5.35M
Fully Diluted Market Cap $5.35M
Market Share %
Trading Vol/Market Cap (24H) 49,587.03%
Circulation Supply 4.32K
Max Supply 0
Total Supply 4,319.10365876
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 1294.592530663292, 2026-08-19
Lowest Price 712.8133541417105, 2025-09-25
Public Blockchain LLYON
Introduction li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Sector
- common.mc-trade-zone-xStocks
Social Media
Fund Flow Analysis
|
Buy(LLYON) |
Sell(LLYON) |
Net Inflow |
| Big |
1.489K |
792.312 |
696.708 |
| Medium |
84.093 |
565.400 |
-481.307 |
| Small |
8.033K |
8.913K |
-879.459 |
| Total |
9.606K |
10.270K |
-664.058 |
Disclaimer: Data provided by cmc and should not be considered as investment advice.